+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 10Years - 46Years
All Genders
Healthy Volunteers
ID06059521

Study Comparing Software-Based Eye Refraction Using Mobilerone With Retinoscopy for Myopia and Astigmatism in Older Children and Adults

Led by Beijing Airdoc Technology Co., Ltd. · Updated on 2023-09-28

120

Participants Needed

3

Research Sites

260 weeks

Total Duration

AI-Summary

What This Trial Is About

The trial investigates a new software refraction technology installed on a mobilerone device, designed to measure myopic refractive errors with or without astigmatism in adults and older children. Researchers aim to test the accuracy, effectiveness, and safety of this software compared to the traditional retinoscopy method. This study is a randomized controlled trial to compare the two refraction methods in participants with myopia or astigmatism. Participants are randomly assigned to one of two groups. One group uses the software refraction app on the mobilerone device, which provides subjective guidance on screen during the test. The other group undergoes objective refraction using retinoscopy with a retinoscope. Both methods are evaluated for their refractive results, including spherical equivalence, astigmatism power, astigmatism axis, and pupil distance. During the study, participants will have their refraction measured at the start and within two weeks. Researchers will also track the time taken to complete each test. Participants need to cooperate with the screening and operators, and assessments include vision acuity checks and eye health evaluations. The trial includes adults and older children aged 10 to 46 years, with follow-up visits scheduled to assess the primary outcomes related to refraction accuracy and test efficiency.

CONDITIONS

Brief Title

Software Refraction With Mobilerone Versus Retinoscopy

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here